scholarly journals A polymorphism in the fatty acid desaturase-2 gene is associated with the arachidonic acid metabolism in pigs

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Sofia Gol ◽  
Ramona N. Pena ◽  
Max F. Rothschild ◽  
Marc Tor ◽  
Joan Estany
1993 ◽  
Vol 128 (5) ◽  
pp. 478-484
Author(s):  
MP de la Llosa-Hermier ◽  
C Fernandez ◽  
J Martal ◽  
C Hermier

The present study was conducted to investigate whether arachidonic acid and its metabolites can modulate progesterone (P4) secretion in ovine chorionic cells. At concentrations of 7.5 μmol/l and 12.5 μmol/l, arachidonic acid caused an increase of basal P4 secretion (about 1.8-fold (p< 0.01) and 2.5-fold (p<0.001), respectively, over control). Such a stimulatory effect was suppressed when the concentration of arachidonic acid attained 25 μmol/l, and at 50 μmol/l the fatty acid led to a decline of basal P4 synthesis (about 35%, p <0.01). Phospholipase A2 (PLA2) and melittin had a similar dual effect to that observed when arachidonic acid was added exogenously. In contrast, eicosatrienoic acid (a closely related fatty acid) did not stimulate P4 secretion but inhibited it at a concentration of 50 μmol/l (about 40% inhibition, p <0.01). The possible involvement of calcium on the effects of arachidonic acid was explored. Interestingly, 3 mmol/l ethylene glycol bis(β-aminoethyl ether)-N,N,N,N′-tetraacetic acid (EGTA) and 10 μmol/l 8-N, N-diethylamino-octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8) further enhanced the steroidogenic effect of 12.5 μmol/l arachidonic acid (p<0.05 and p<0.01 vs the corresponding value in the absence of EGTA or TMB-8, respectively). In contrast, these agents failed to modify P4 secretion observed in the presence of 50 μmol/l arachidonic acid. We also tested the effect of inhibition of arachidonic acid metabolism via cyclooxygenase and lipoxygenase pathways. Indomethacin (10 μmol/l) failed to block the effects of arachidonic acid, but nordihydroguaiaretic acid (10 μmol/l) prevented the stimulatory action of this fatty acid. Taken together, these data suggest that arachidonic acid and its metabolites (perhaps its lipoxygenated metabolites) may be important intracellular regulators of P4 secretion in ovine chorionic cells.


2013 ◽  
Vol 2013 ◽  
pp. 1-12 ◽  
Author(s):  
Rongcai Yue ◽  
Ling Zhao ◽  
Yaohua Hu ◽  
Peng Jiang ◽  
Shuping Wang ◽  
...  

Huang-Lian-Jie-Du-Tang (HLJDT) is a traditional Chinese medicine (TCM) with anti-inflammatory activity. The present study used a metabolomic approach based on LC-Q-TOF-MS to profile rheumatoid-arthritis- (RA-) related metabolic changes and to investigate the interventional mechanisms of HLJDT in collagen-induced arthritis rats. Forty male Wistar rats were randomly divided into five groups: (1) a model group, (2) a normal control group, (3) a dexamethasone group, (4) a HLJDT group, and (5) a group that received 13 components of HLJDT. Plasma samples were collected 8, 15, and 22 days after the rats were injected with bovine type II collagen. By combining variable importance in the projection values with partial least squares discriminant analysis, 18 potential biomarkers were identified in the plasma samples. The biomarkers were primarily involved in glycerophospholipid metabolism, fatty acid metabolism, tryptophan metabolism, linoleic acid metabolism, phenylalanine metabolism, purine metabolism, arachidonic acid metabolism, and bile acid biosynthesis. Using the potential biomarkers as a screening index, the results suggest that HLJDT can potentially reverse the process of RA by partially regulating fatty acid oxidation and arachidonic acid metabolism. This study demonstrates that a metabolomic strategy is useful for identifying potential RA biomarkers and investigating the underlying mechanisms of a TCM in RA treatment.


1986 ◽  
Vol 5 (6) ◽  
pp. 441-448 ◽  
Author(s):  
T. Sanjeeva Reddy ◽  
Dale L. Birkle ◽  
Andrew J. Packer ◽  
Paul Dobard ◽  
Nicolas G. Bazan

2021 ◽  
Vol 22 (14) ◽  
pp. 7680
Author(s):  
Denisa Miklankova ◽  
Irena Markova ◽  
Martina Hüttl ◽  
Iveta Zapletalova ◽  
Martin Poruba ◽  
...  

Metformin can reduce cardiovascular risk independent of glycemic control. The mechanisms behind its non-glycemic benefits, which include decreased energy intake, lower blood pressure and improved lipid and fatty acid metabolism, are not fully understood. In our study, metformin treatment reduced myocardial accumulation of neutral lipids—triglycerides, cholesteryl esters and the lipotoxic intermediates—diacylglycerols and lysophosphatidylcholines in a prediabetic rat model (p < 0.001). We observed an association between decreased gene expression and SCD-1 activity (p < 0.05). In addition, metformin markedly improved phospholipid fatty acid composition in the myocardium, represented by decreased SFA profiles and increased n3-PUFA profiles. Known for its cardioprotective and anti-inflammatory properties, metformin also had positive effects on arachidonic acid metabolism and CYP-derived arachidonic acid metabolites. We also found an association between increased gene expression of the cardiac isoform CYP2c with increased 14,15-EET (p < 0.05) and markedly reduced 20-HETE (p < 0.001) in the myocardium. Based on these results, we conclude that metformin treatment reduces the lipogenic enzyme SCD-1 and the accumulation of the lipotoxic intermediates diacylglycerols and lysophosphatidylcholine. Increased CYP2c gene expression and beneficial effects on CYP-derived arachidonic acid metabolites in the myocardium can also be involved in cardioprotective effect of metformin.


2020 ◽  
Author(s):  
Isabelle K. Vila ◽  
Hanane Chamma ◽  
Alizée Steer ◽  
Clara Taffoni ◽  
Line S. Reinert ◽  
...  

AbstractInflammatory disorders are major health issues in which immune function and metabolic homeostasis are concertedly altered. Yet, how innate and metabolic pathways are coordinated, in homeostatic conditions, is poorly understood. Here, we demonstrate that the Stimulator of interferon genes (Sting) inhibits the Fatty acid desaturase 2 (Fads2) rate limiting enzyme in polyunsaturated Fatty acid desaturation, thereby controlling both Fatty acid (FA) metabolism and innate immunity. Indeed, we show that Sting activation increased Fads2 activity, while decreasing Fads2 levels enhanced Sting activation, establishing an anti-viral state. Remarkably, the cross-regulation between Sting and Fads2 is mediated by the cyclic GMP-AMP (cGAMP) Sting agonist and PUFAs. Indeed, PUFAs inhibit Sting activation, while cGAMP binds Fads2 and promotes its degradation. Thus, our study identifies Sting as a master regulator of the interplay between FA metabolism and inflammation.One Sentence SummarySting inhibits polyunsaturated fatty acid metabolism.


1985 ◽  
Vol 110 (1_Suppla) ◽  
pp. S53-S54
Author(s):  
ST. NIESERT ◽  
M. D. MITCHELL ◽  
M. L. CASEY ◽  
P. C. MACDONALD

Sign in / Sign up

Export Citation Format

Share Document